Harnessing the potential of multimodal radiotherapy in prostate cancer

Harnessing the potential of multimodal radiotherapy in prostate cancer

Radiotherapy in combination with androgen deprivation therapy (ADT) is a standard treatment option for men with localized and locally advanced prostate cancer. However, emerging clinical evidence suggests that radiotherapy can be incorporated into multimodality therapy regimens beyond ADT, in combin...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Philippou, Y, Sjoberg, H, Lamb, AD, Camilleri, P, Bryant, RJ
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Springer Nature 2020

Míreanna comhchosúla

Investigating tumour immune microenvironment effects of hypofractionated radiotherapy +/- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models
de réir: Y Philippou, et al.
Foilsithe / Cruthaithe: (2020-07-01)

8 Novel enhancement of multimodality treatment of prostate cancer, combining radiotherapy,vascular-targeted photodynamic therapy, and immunotherapy
de réir: H.T. Sjoberg, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
de réir: Philippou, Y, et al.
Foilsithe / Cruthaithe: (2020)

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
de réir: Charlton, P, et al.
Foilsithe / Cruthaithe: (2023)

Harnessing the power of RNA in determining the origin of lethal micro-metastatic prostate cancer
de réir: A.M. Erickson, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Re: Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study
de réir: Philippou, Y, et al.
Foilsithe / Cruthaithe: (2020)

Investigating multi-modal therapy with radiotherapy, vascular-targeted photodynamic therapy and immunotherapy in pre-clinical models of prostate cancer
de réir: Philippou, Y
Foilsithe / Cruthaithe: (2021)

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease
de réir: Charlton, PV, et al.
Foilsithe / Cruthaithe: (2024)

Orient expression: solving the mystery of Asian prostate cancer?
de réir: Lamb, A, et al.
Foilsithe / Cruthaithe: (2017)

Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?
de réir: Berridge, C, et al.
Foilsithe / Cruthaithe: (2024)

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial
de réir: Marian, IR, et al.
Foilsithe / Cruthaithe: (2024)

Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
de réir: Wu, X, et al.
Foilsithe / Cruthaithe: (2019)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2008-10-01)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2007-10-01)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2008-07-01)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2007-01-01)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2007-04-01)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2008-01-01)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2007-07-01)

Redaktören har ordet
de réir: Katarina Sjöberg
Foilsithe / Cruthaithe: (2008-04-01)

The use of digital pathology and artificial intelligence in histopathological diagnostic assessment of prostate cancer: a survey of prostate cancer UK supporters
de réir: Rakovic, K, et al.
Foilsithe / Cruthaithe: (2022)

A systematic review of prostate cancer heterogeneity: understanding the clonal ancestry of multifocal disease
de réir: Erickson, A, et al.
Foilsithe / Cruthaithe: (2021)

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
de réir: Hamdy, FC, et al.
Foilsithe / Cruthaithe: (2023)

Treatment of breast and prostate cancer by hypofractionated radiotherapy: potential risks and benefits
de réir: Ray, KJ, et al.
Foilsithe / Cruthaithe: (2015)

Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer
de réir: Sefora Conti MSc, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits
de réir: Ray, K, et al.
Foilsithe / Cruthaithe: (2015)

Harnessing uncertainty in radiotherapy auto-segmentation quality assurance
de réir: Kareem A. Wahid, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Updates on Radiotherapy for Localized Prostate Cancer
de réir: Alexandros Papachristofilou
Foilsithe / Cruthaithe: (2023-12-01)

Advances in Radiotherapy for Prostate Cancer Treatment
de réir: Tarun Podder, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Editorial: Advances in radiotherapy for prostate cancer
de réir: Sophia C. Kamran, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Stereotactic Body Radiotherapy for Prostate Cancer
de réir: Neil R. Parikh M.D., et al.
Foilsithe / Cruthaithe: (2020-06-01)

MR-Guided Radiotherapy for Prostate Cancer
de réir: Boris R. Tocco, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Multimodality functional imaging in rectal cancer treated with radiotherapy
de réir: Greenhalgh, T
Foilsithe / Cruthaithe: (2022)

Impact of age on treatment response in men with prostate cancer treated with radiotherapy
de réir: Alex K. Bryant, et al.
Foilsithe / Cruthaithe: (2022-05-01)

The tumor microenvironment and immune responses in prostate cancer patients
de réir: Kwon, JTW, et al.
Foilsithe / Cruthaithe: (2021)

Diagnostic pathways for screen-detected prostate cancer: The plot thickens
de réir: Hamdy, F, et al.
Foilsithe / Cruthaithe: (2017)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
de réir: Lamb, A, et al.
Foilsithe / Cruthaithe: (2018)

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy
de réir: Kachris S, et al.
Foilsithe / Cruthaithe: (2021-11-01)

From microbes to medicine: harnessing the gut microbiota to combat prostate cancer
de réir: Anjali Yadav, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Harnessing machine learning to predict prostate cancer survival: a review
de réir: Sungun Bang, et al.
Foilsithe / Cruthaithe: (2025-01-01)